CXCL10 and neoplasm: Expression of CXCL10 in breast cancer can enhance tumour-specific T cell infiltration, and is associated with increased overall patient survival [6]; similarly, the delivery of CXCL10-loaded nanoparticles inhibits the growth of liver tumours [7].